CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men
- 11 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (14) , 1879-1883
- https://doi.org/10.1097/01.aids.0000244207.49123.ff
Abstract
To test the hypothesis that in comparison with those with shorter risk duration, individuals with longer HIV risk duration would have reduced susceptibility to HIV-1 infection as measured by CCR5 expression, and to evaluate whether variation in CCR5 expression could be explained by known genetic polymorphisms. A cross-sectional study of HIV-1 exposed but uninfected men who have sex with men. The risk duration was estimated from self-reported years since first receptive anal intercourse. CCR5 expression on peripheral blood CD4+ monocytes and T cells was determined by flow cytometry. The CCR5-Δ32 mutation and polymorphisms in the CCR5 promoter and CCR2 as well as the copy number of CCL3L1 were analyzed by polymerase chain reaction. Plasma levels of MIP-1α (CCL3), MIP-1β (CCL4) and RANTES (CCL5) were also measured. As risk duration varied with age, analyses were restricted to 67 individuals aged 30–49 years. Multiple linear regression analyses, adjusted for age and race, showed a significant negative association between HIV risk duration and CCR5 expression on monocytes (P = 0.01), and in a separate model, a similar negative association with CCR5 expression on T cells (P = 0.03). Low CCR5 expression was attributable mainly to CCR5-Δ32 heterozygosity and the CCR5-59029G allele. We confirmed a role for reduced CCR5 expression in HIV-1 resistance. CCR5-Δ32 heterozygosity and the CCR5-59029G allele were significant predictors of low CCR5 expression. Individuals with high CCR5 expression who resisted infection despite long HIV risk duration form an interesting group within which to search for additional mechanisms of resistance to HIV infection.Keywords
This publication has 24 references indexed in Scilit:
- CCR2-64I and CXCL12 3′A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapyJournal of Clinical Virology, 2005
- Beliefs about HIV Non-Infection and Risky Sexual Behavior among MSMAIDS Education and Prevention, 2004
- Macrophage HIV-1 infection and the gastrointestinal tract reservoirJournal of Leukocyte Biology, 2003
- Homozygous and Heterozygous CCR5-Δ32 Genotypes Are Associated With Resistance to HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality.The Journal of Infectious Diseases, 2001
- CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressorsAIDS, 2000
- Protective Effect of CCR2-64I and Not of CCR5-Δ32 and SDF1-3´A in Pediatric HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Chemokine Receptor Polymorphisms and Human Immunodeficiency Virus Disease ProgressionThe Journal of Infectious Diseases, 1999
- Mucosal Events in the Pathogenesis of Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 1999
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996